Search company, investor...
Human Longevity company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Acq - Pending | Acquired

Total Raised




About Human Longevity

Human Longevity is building a comprehensive database of human genotypes and phenotypes as a basis for a variety of commercialization opportunities to help solve aging-related disease and human biological decline. The company is developing and applying large-scale computing and machine learning to make discoveries from this data to generate personalized health insights. Its goal is to extend healthy human life by impacting human health and transforming the practice of medicine. Human Longevity was founded in 2013 and is based in San Diego, California.

Human Longevity Headquarters Location

4570 Executive Drive

San Diego, California, 92121,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Human Longevity

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Human Longevity in 1 CB Insights research brief, most recently on Apr 13, 2020.

Expert Collections containing Human Longevity

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Human Longevity is included in 4 Expert Collections, including Omics.



1,542 items


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.



69 items


Drug Discovery Tech Market Map

221 items

This CB Insights Tech Market Map highlights 220 drug discovery companies that are addressing 12 distinct technology priorities that pharmaceutical companies face.

Human Longevity Patents

Human Longevity has filed 15 patents.

The 3 most popular patent topics include:

  • Bioinformatics
  • Genetics
  • Molecular biology
patents chart

Application Date

Grant Date


Related Topics




Health informatics, Biological databases, Medical diagnosis, Molecular biology, Biotechnology


Application Date


Grant Date



Related Topics

Health informatics, Biological databases, Medical diagnosis, Molecular biology, Biotechnology



Latest Human Longevity News

04:00 EDT Methuselah Foundation Unveils ELONgevity Protection to Support Human Longevity Initiatives, Provide Access to Promisin...

Sep 20, 2022

News provided by Share this article Share this article Dogelon Mars (ELON) will be the key for terminally ill participants to unlock investigational treatments that offer a fighting chance to overcome deadly diseases DUBLIN, Sept. 20, 2022 /CNW/ -- Methuselah Foundation Co-founder and CEO David Gobel announced the formation of the ELONgevity Protection Project to promote human anti-aging efforts and provide members diagnosed with terminal diseases access to experimental therapies that promise a chance of survival. While life insurance pays a benefit when a policy holder dies, ELONgevity Protection makes every effort to extend lives by actively working to get terminally ill members enrolled in scientifically promising experimental therapies, including appropriate clinical trials. The initiative's ELONgevity Protection Clearing House will locate medical teams creating experimental treatments or programs that offer terminally diagnosed members a chance of successful application. Then an affected member will receive $50,000 to cover expenses associated with the experimental treatment and related travel and living costs. If the member dies, the contract value will be paid out to the survivor. Because the initiative is operated by the nonprofit Methuselah Foundation, all member payments, after expenses, will be used to support ongoing longevity research. "We are bringing longevity research to life at both the societal and individual levels," said Gobel. "The Project's work will encourage research to help us achieve the Methuselah Foundation mission of making 90 the new 50 by 2030. The Clearing House will seek to make experimental research available to individuals, providing them with a last chance to cure their terminal disease." The initiative is currently recruiting 300 Alpha Testers who will each pay $1,000 in Dogelon Mars (ELON) tokens to participate in the Protection Clearing House. This is the first crypto transaction for the ELON that extends beyond the Dogelon Mars community and is one of the first uses of crypto that will deliver valuable off-chain utility. ELONgevity Protection Project is the latest initiative by Methuselah Foundation, the preeminent biomedical charity focused on extending the healthy human lifespan. It was announced at Longevity Summit Dublin, the world's first gathering of leading longevity entrepreneurs, biotech companies, researchers and investors. About Methuselah Foundation Methuselah Foundation is a biomedical charity established in 2001, and named after Methuselah, the grandfather of Noah in the Hebrew Bible, whose lifespan was recorded as 969 years. The Foundation's mission is to make age 90 the new 50 by 2030. The organization has funded independent longevity research, underwritten several international competitions aimed at promoting scientific breakthroughs, financed dozens of companies and initiatives developing products to extend the healthy human lifespan and created or sponsored four other foundations and venture funds to promote the mission of extending healthy life. For more information, visit the Foundation website, or check it out on Twitter , Facebook , Instagram  or LinkedIn . For more information, contact:

Human Longevity Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Human Longevity Rank

  • When was Human Longevity founded?

    Human Longevity was founded in 2013.

  • Where is Human Longevity's headquarters?

    Human Longevity's headquarters is located at 4570 Executive Drive, San Diego.

  • What is Human Longevity's latest funding round?

    Human Longevity's latest funding round is Acq - Pending.

  • How much did Human Longevity raise?

    Human Longevity raised a total of $330M.

  • Who are the investors of Human Longevity?

    Investors of Human Longevity include Freedom Acquisition I, Emerging Technology Partners, Threshold Ventures, GE Ventures, Amino Capital and 5 more.

  • Who are Human Longevity's competitors?

    Competitors of Human Longevity include FOXO Technologies and 8 more.

You May Also Like

Helix Logo

Helix connects people with the most fundamental aspect of what makes them unique: their own DNA. The company empowers consumers to discover and explore their own genomes through insights provided by its ecosystem of content partners.

Color Logo

Color democratizes access to genetic information. The Color Test is physician-ordered and comes with complimentary board-certified genetic counseling for clients and healthcare providers. The 30-gene Color Test analyzes genes closely associated with some of the most common hereditary cancers: breast, colorectal, melanoma, ovarian, pancreatic, prostate, stomach, and uterine cancers.

Prosper eDNA

Prosper eDNA increases accuracy and planning for insurance companies working in life, long-term care and annuities by making accurate lifespan predictions, and enabling personalized epigenetic (not genetic) monitoring.

Ancestry Logo

Ancestry offers a website offering family history information, historical records and other genealogical information. offers several localized Web sites designed to empower people to discover, preserve and share family history. Ancestry has more than 2.2 million paying subscribers across its core Ancestry websites and approximately 1.5 million DNA samples in the AncestryDNA database.

Nalagenetics Logo

Nalagenetics is a genetic testing company that aims to create cost-effective tests tailored to Asian populations. The company also offers products for COVID-19, Pharmacogenomics, and Nutrigenetics. The company was founded in 2016 and is based in Singapore.

OmeCare Logo

OmeCare provides physicians and their patients with genetic information to improve or maintain health and wellness. The company's mobile health applications merge artificial intelligence and deep learning with personal genetic information that provides personalized health and wellness guidance.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.